Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel c-CBL and CBL-b ubiquitin ligase mutations in human acute myeloid leukemia
Michael A. Caligiuri, Roger Briesewitz, Jianhua Yu, et al.
Blood (2007) Vol. 110, Iss. 3, pp. 1022-1024
Open Access | Times Cited: 158

Showing 51-75 of 158 citing articles:

Rapid development of acute monocytic leukemia (AML-M5b) with t(9;11)(p22;q23) after chemotherapy for T-cell lymphoblastic lymphoma: A case report
Jiao Cai, Nan Zhang, Ling Qiu, et al.
Heliyon (2025) Vol. 11, Iss. 4, pp. e42537-e42537
Open Access
Implication of the Molecular Characterization of Acute Myeloid Leukemia
Hartmut Döhner
Hematology (2007) Vol. 2007, Iss. 1, pp. 412-419
Open Access | Times Cited: 55
Molecular mechanisms of thrombopoietin signaling
Kenneth Kaushansky
Journal of Thrombosis and Haemostasis (2009) Vol. 7, pp. 235-238
Open Access | Times Cited: 54
Novel Oncogenic Mutations of CBL in Human Acute Myeloid Leukemia That Activate Growth and Survival Pathways Depend on Increased Metabolism
Margret S. Fernandes, Mamatha M. Reddy, Nicole J. Croteau, et al.
Journal of Biological Chemistry (2010) Vol. 285, Iss. 42, pp. 32596-32605
Open Access | Times Cited: 52
Rapidly fatal myeloproliferative disorders in mice with deletion of Casitas B-cell lymphoma (Cbl) and Cbl-b in hematopoietic stem cells
Mayumi Naramura, Neha Nandwani, Hua Gu, et al.
Proceedings of the National Academy of Sciences (2010) Vol. 107, Iss. 37, pp. 16274-16279
Open Access | Times Cited: 51
The clinical relevance of Wilms Tumour 1 (WT1) gene mutations in acute leukaemia
Carolyn Owen, Jude Fitzgibbon, Peter Paschka
Hematological Oncology (2009) Vol. 28, Iss. 1, pp. 13-19
Closed Access | Times Cited: 49
Parkin deficiency disrupts calcium homeostasis by modulating phospholipase C signalling
Anna Sandebring, Nodi Dehvari, Mónica Pérez‐Manso, et al.
FEBS Journal (2009) Vol. 276, Iss. 18, pp. 5041-5052
Open Access | Times Cited: 48
CBL mutation in chronic myelomonocytic leukemia secondary to familial platelet disorder with propensity to develop acute myeloid leukemia (FPD/AML)
Norio Shiba, Daisuke Hasegawa, Hyuntae Park, et al.
Blood (2011) Vol. 119, Iss. 11, pp. 2612-2614
Open Access | Times Cited: 48
E3 ligase–defective Cbl mutants lead to a generalized mastocytosis and myeloproliferative disease
Srinivasa Rao Bandi, Christian Brandts, Marion Rensinghoff, et al.
Blood (2009) Vol. 114, Iss. 19, pp. 4197-4208
Open Access | Times Cited: 47
Mutant Cbl proteins as oncogenic drivers in myeloproliferative disorders
Mayumi Naramura, Scott Nadeau, Bhopal Mohapatra, et al.
Oncotarget (2011) Vol. 2, Iss. 3, pp. 245-250
Open Access | Times Cited: 47
The fusion proteins TEL-PDGFR and FIP1L1-PDGFR escape ubiquitination and degradation
Federica Toffalini, Anders Kallin, Peter Vandenberghe, et al.
Haematologica (2009) Vol. 94, Iss. 8, pp. 1085-1093
Open Access | Times Cited: 47
Flt3 inhibitor AC220 is a potent therapy in a mouse model of myeloproliferative disease driven by enhanced wild-type Flt3 signaling
Samuel J. Taylor, Samantha A. Dagger, Christine B.F. Thien, et al.
Blood (2012) Vol. 120, Iss. 19, pp. 4049-4057
Open Access | Times Cited: 39
Role of the ubiquitin proteasome system in hematologic malignancies
Anagh A. Sahasrabuddhe, Kojo S.J. Elenitoba‐Johnson
Immunological Reviews (2014) Vol. 263, Iss. 1, pp. 224-239
Open Access | Times Cited: 36
Deregulated Intracellular Signaling by Mutated c-CBL in Myeloid Neoplasms
Seishi Ogawa, Lee‐Yung Shih, Takahiro Suzuki, et al.
Clinical Cancer Research (2010) Vol. 16, Iss. 15, pp. 3825-3831
Open Access | Times Cited: 39
Smap1 deficiency perturbs receptor trafficking and predisposes mice to myelodysplasia
Shunsuke Kon, Naoko Minegishi, Kenji Tanabe, et al.
Journal of Clinical Investigation (2013) Vol. 123, Iss. 3, pp. 1123-1137
Open Access | Times Cited: 34
Progress in RNAi-mediated Molecular Therapy of Acute and Chronic Myeloid Leukemia
Breanne Landry, Juliana Valencia‐Serna, Hilal Gül-Uludağ, et al.
Molecular Therapy — Nucleic Acids (2015) Vol. 4, pp. e240-e240
Open Access | Times Cited: 33
Clonal selection of 11q CN-LOH and CBL gene mutation in a serially studied patient during MDS progression to AML
Vincenza Barresi, Giuseppe A. Palumbo, Nicolò Musso, et al.
Leukemia Research (2010) Vol. 34, Iss. 11, pp. 1539-1542
Closed Access | Times Cited: 35
Global Cell Proteome Profiling, Phospho-signaling and Quantitative Proteomics for Identification of New Biomarkers in Acute Myeloid Leukemia Patients
Elise Aasebø, Rakel Brendsdal Forthun, Frode S. Berven, et al.
Current Pharmaceutical Biotechnology (2015) Vol. 17, Iss. 1, pp. 52-70
Open Access | Times Cited: 27
Myeloid neoplasms with germ line RUNX1 mutation
Yoshihiro Hayashi, Yuka Harada, Gang Huang, et al.
International Journal of Hematology (2017) Vol. 106, Iss. 2, pp. 183-188
Closed Access | Times Cited: 27
E3 ubiquitin ligase Casitas B lineage lymphoma-b and its potential therapeutic implications for immunotherapy
Davood Jafari, Mohammad Javad Mousavi, Sanaz Keshavarz Shahbaz, et al.
Clinical & Experimental Immunology (2020) Vol. 204, Iss. 1, pp. 14-31
Open Access | Times Cited: 22
The ubiquitin ligase Triad1 inhibits myelopoiesis through UbcH7 and Ubc13 interacting domains
Jurgen A. Marteijn, Laurens T. van der Meer, Judith J. Smit, et al.
Leukemia (2009) Vol. 23, Iss. 8, pp. 1480-1489
Closed Access | Times Cited: 29
The Genetic Basis of Myelodysplastic Syndromes
Rafael Bejar, Benjamin L. Ebert
Hematology/Oncology Clinics of North America (2010) Vol. 24, Iss. 2, pp. 295-315
Closed Access | Times Cited: 29
Mutations of c-Cbl in myeloid malignancies
Shulamit Katzav, M. Lienhard Schmitz
Oncotarget (2015) Vol. 6, Iss. 13, pp. 10689-10696
Open Access | Times Cited: 21
Ubiquitin ligase Cbl‐b sensitizes leukemia and gastric cancer cells to anthracyclines by activating the mitochondrial pathway and modulating Akt and ERK survival signals
Xiujuan Qu, Ye Zhang, Yingchun Li, et al.
FEBS Letters (2009) Vol. 583, Iss. 13, pp. 2255-2262
Open Access | Times Cited: 26
CBL mutations in myeloproliferative neoplasms are also found in the gene's proline-rich domain and in patients with the V617FJAK2
Paula Aranaz, C. Hurtado, I. Erquiaga, et al.
Haematologica (2012) Vol. 97, Iss. 8, pp. 1234-1241
Open Access | Times Cited: 23

Scroll to top